Collegium Pharma (COLL) Announces $50 Million Accelerated Share Repurchase Program

August 7, 2023 7:30 AM EDT Send to a Friend
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login